Cymbalta and Lichen planus aggravated - a phase IV clinical study of FDA data

Summary:

Lichen planus aggravated is reported as a side effect among people who take Cymbalta (duloxetine hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Fish Oil, and have Major depression.

The phase IV clinical study analyzes which people have Lichen planus aggravated when taking Cymbalta. It is created by eHealthMe based on reports of 145,249 people who have side effects when taking Cymbalta from the FDA, and is updated regularly.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,973 Cymbalta users. Check the latest studies of Cymbalta.

What is Lichen planus aggravated?

Lichen planus aggravated (a inflammatory skin condition, characterized by an itchy, non-infectious rash) is found to be associated with 284 drugs and 326 conditions by eHealthMe. Check the latest studies of Lichen planus aggravated.

On Jul, 29, 2026

145,249 people reported to have side effects when taking Cymbalta.
Among them, 25 people (0.02%) have Lichen planus aggravated.

Could Cymbalta cause Lichen planus aggravated?

Among these 25 people:

How long have people been on Cymbalta when they have Lichen planus aggravated? *

What is the gender of people who have Lichen planus aggravated when taking Cymbalta? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Lichen planus aggravated when taking Cymbalta? *

What are other drugs people take besides Cymbalta? *

What are other side effects people have besides Lichen planus aggravated? *

Blood Creatine Phosphokinase Increased: 8 people, 32.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 12.00%
Neurodermatitis (a skin disorder characterized by long lasting itching and scratching): 3 people, 12.00%
Scar: 2 people, 8.00%
Itching: 2 people, 8.00%
Drug Ineffective: 2 people, 8.00%
Cerebral Cyst (fluid filled tumour of brain): 2 people, 8.00%
Stomatitis (inflammation of mucous membrane of mouth): 2 people, 8.00%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 2 people, 8.00%
Dry Skin: 2 people, 8.00%

What are the existing conditions these people have? *

Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 8 people, 32.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 28.00%
Dyslipidaemia (abnormal amount of lipids): 6 people, 24.00%
Diabetes: 6 people, 24.00%
Neurodermatitis (a skin disorder characterized by long lasting itching and scratching): 2 people, 8.00%
Sleep Disorder: 1 person, 4.00%
Osteoporosis (bones weak and more likely to break): 1 person, 4.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 4.00%
Neuropathy Peripheral (surface nerve damage): 1 person, 4.00%
Muscle Disorder (muscle disease): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cymbalta and have Lichen planus aggravated?

- Check whether Lichen planus aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cymbalta:

Cymbalta (154,973 reports)

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lichen planus aggravated:

Lichen planus aggravated (284 drugs)

Browse all the conditions that are associated with Lichen planus aggravated:

Lichen planus aggravated (326 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on duloxetine hydrochloride (the active ingredients of Cymbalta) and Cymbalta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.